Brief: Senti Biosciences Says CFO Deborah Knobelman Notified Co Of Decision To Resign From Company
April 26 (Reuters) - Senti Biosciences Inc SNTI.O :
* SENTI BIOSCIENCES INC - ON APRIL 23, DEBORAH KNOBELMAN,
CO'S
CHIEF FINANCIAL OFFICER NOTIFIED CO OF DECISION TO RESIGN FROM
COMPANY, EFFECTIVE MAY 3
Further company coverage: SNTI.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Senti Biosciences Holdings
See all newsBrief: Senti Biosciences Says Offering 15.97 Million Shares Of Common Stock For Resale By Selling Securityholder
Senti Biosciences Q1 net loss narrows on cost reduction
Brief: Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy
Brief: Senti Biosciences Announces Holding Company Reorganization Effective By April 16, 2026 - SEC Filing
Senti Biosciences Q4 revenue misses analyst estimates